Low-dose oral methotrexate in refractory inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 38, Issue 10, 1993, Pages 1851-1856

  Baron, Todd H ^a   Truss, Christopher D ^a   Elson, Charles O ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Crohn's disease; methotrexate; refractory inflammatory bowel disease; ulcerative colitis

Indexed keywords

CORTICOSTEROID; METHOTREXATE; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ADULT; COLITIS, ULCERATIVE; COMPARATIVE STUDY; CROHN DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; METHOTREXATE; PILOT PROJECTS; PREDNISONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0027454451     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/BF01296109     Document Type: Article

References (22)

1. Methotrexate in rheumatoid arthritis
2. Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians Guidelines
3. Comparison of low dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial
4. Weekly pulse methotrexate in rheumatoid arthritis
5. Efficacy of low-dose methotrexate in rheumatoid arthritis
6. Methotrexate
7. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study
8. Methotrexate treatment of severe asthma in children
9. Methotrexate indices for clinical and histologic remission in patients with refractory inflammatory bowel disease
10. Does oral methotrexate (MTX) therapy maintain clinical remission in inflammatory bowel disease (IBD)?
11. Pharmacokinetics of small doses of methotrexate in patients with psoriasis
12. The OMGE Multinational Inflammatory Bowel Disease Survey
13. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study
14. Immunosuppressant therapy of inflammatory bowel disease. Pharmacologic and clinical aspects
15. Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy
16. Advances in drug therapy for inflammatory bowel disease
17. Long-term immunosuppressive treatment in Crohn's disease
18. Immunosuppressive agents (IA) in the treatment of Crohn's disease including ileitis and ileocolitis
19. Efficacy of 6-mercaptopurine in refractory ulcerative colitis
20. The “natural history” of ulcerative colitis: an analysis of the placebo response
21. “Natural history” of Crohn's disease. An analytic review of the placebo lesson
22. A double-blind, randomized, placebo-controlled trial of methotrexate in Crohn's disease